{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:41:12Z","timestamp":1791578472761,"version":"4.3.4"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:00:00Z","timestamp":1740960000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Under hyperglycemic conditions, impaired intestinal barrier integrity leads to heightened level of inflammation, playing important roles in driving diabetic complications. Emerging evidence supports the implications of neutrophil extracellular traps (NETs) in the pathogenesis of diabetes. However, whether NETs contribute to hyperglycemia-linked intestinal barrier impairment remains to be investigated. Moreover, baicalin, the major chemical component of Scutellaria baicalensis Georgi, is equipped with twofold intestinal protective and neutrophil suppressive activities. Yet, it is unclear if baicalin is effective at mitigating hyperglycemia-linked NETs-mediated intestinal barrier impairment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>To directly address the mechanistic implications of NETs in hyperglycemia-linked intestinal epithelial barrier impairment, the impact of DNase I treatment or <jats:italic>Padi4<\/jats:italic> gene deficiency on intestinal epithelial integrity was first examined in the streptozotocin (STZ)-induced hyperglycemic mice <jats:italic>in vivo<\/jats:italic>. Next, the pharmacological impact of baicalin on NETs formation and intestinal epithelial barrier impairment was investigated in high glucose- and\/or lipopolysaccharides (LPS)-stimulated neutrophils <jats:italic>in vitro<\/jats:italic> and in STZ-induced hyperglycemic mice <jats:italic>in vivo<\/jats:italic>, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The <jats:italic>in vitro<\/jats:italic> experiments confirmed that high glucose and\/or LPS induced NETs formation. NETs directly impaired the viability and tight junction of the intestinal epithelial cells. The histological and immunohistochemical examinations unveiled that along with impaired intestinal epithelial morphology, citrullinated histone H3 (H3Cit), a marker of NETs, and neutrophil specific Ly6G were readily detected in the intestinal epithelium in the hyperglycemic mice. Without affecting the presence of neutrophils, DNase I treatment or <jats:italic>Padi4<\/jats:italic> gene deficiency markedly mitigated intestinal NETs formation and improved the intestinal morphology in the hyperglycemic mice. Notably, baicalin suppressed NETs formation and inhibited histone H3 citrullination stimulated by high glucose, LPS or both <jats:italic>in vitro<\/jats:italic>. Furthermore, baicalin blunted NETs formation and partially preserved the integrity of the intestinal epithelium in the hyperglycemic mice <jats:italic>in vivo<\/jats:italic>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The current study sheds new light on the pathophysiological implications of NETs in intestinal epithelial barrier impairment under hyperglycemic conditions. Most importantly, the findings here demonstrate for the first time that baicalin directly inhibits NETs formation stimulated by high glucose and\/or LPS, which may in part account for its pharmacological effects at protecting against hyperglycemia-linked intestinal epithelial barrier impairment.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1551256","type":"journal-article","created":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T07:04:21Z","timestamp":1740985461000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Baicalin mitigates hyperglycemia-linked intestinal epithelial barrier impairment in part by inhibiting the formation of neutrophil extracellular traps"],"prefix":"10.3389","volume":"16","author":[{"given":"Yiqing","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinbo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinmiao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingang","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoye","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.15420\/ecr","article-title":"The role of inflammation in diabetes: current concepts and future perspectives","volume":"14","author":"Tsalamandris","year":"2019","journal-title":"Eur Cardiol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar3318","article-title":"Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection","volume":"359","author":"Thaiss","year":"2018","journal-title":"Science"},{"key":"B3","doi-asserted-by":"publisher","first-page":"104821","DOI":"10.1016\/j.ebiom.2023.104821","article-title":"Gut microbiota in the pathogenesis and therapeutic approaches of diabetes","volume":"97","author":"Crudele","year":"2023","journal-title":"EBioMedicine"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-04-457671","article-title":"NETosis: how vital is it","volume":"122","author":"Yipp","year":"2013","journal-title":"Blood"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.03076","article-title":"Hyperglycemia induces neutrophil extracellular traps formation through an NADPH oxidase-dependent pathway in diabetic retinopathy","volume":"9","author":"Wang","year":"2018","journal-title":"Front Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"R65","DOI":"10.1530\/JME-20-0128","article-title":"NETosis contributes to the pathogenesis of diabetes and its complications","volume":"65","author":"Njeim","year":"2020","journal-title":"J Mol Endocrinol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1202463","article-title":"Diabetes-associated neutrophil NETosis: pathogenesis and interventional target of diabetic complications","volume":"14","author":"Zhu","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B9","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s00592-014-0676-x","article-title":"NETosis is induced by high glucose and associated with type 2 diabetes","volume":"52","author":"Menegazzo","year":"2015","journal-title":"Acta Diabetol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3887","article-title":"Diabetes primes neutrophils to undergo NETosis, which impairs wound healing","volume":"21","author":"Wong","year":"2015","journal-title":"Nat Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines8080275","article-title":"Neutrophil extracellular traps impair intestinal barrier function during experimental colitis","volume":"8","author":"Lin","year":"2020","journal-title":"Biomedicines"},{"key":"B12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s43440-019-00024-x","article-title":"Baicalin and its aglycone: a novel approach for treatment of metabolic disorders","volume":"72","author":"Fang","year":"2020","journal-title":"Pharmacol Rep"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24031954","article-title":"Therapeutic potential of bioactive components from scutellaria baicalensis georgi in inflammatory bowel disease and colorectal cancer: A review","volume":"24","author":"Jang","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25010431","article-title":"The anti-diabetic potential of baicalin: evidence from rodent studies","volume":"25","author":"Szkudelski","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.joim.2024.09.003","article-title":"A comprehensive overview on antiviral effects of baicalein and its glucuronide derivative baicalin","volume":"22","author":"Liu","year":"2024","journal-title":"J Integr Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22052315","article-title":"Baicalin-induced autophagy preserved LPS-stimulated intestinal cells from inflammation and alterations of paracellular permeability","volume":"22","author":"Rizzo","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01271","article-title":"Baicalin protects against hypertension-associated intestinal barrier impairment in part through enhanced microbial production of short-chain fatty acids","volume":"10","author":"Wu","year":"2019","journal-title":"Front Pharmacol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(03)01378-5","article-title":"Mechanisms in mediating the anti-inflammatory effects of baicalin and baicalein in human leukocytes","volume":"465","author":"Shen","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.a.v83a.2","article-title":"Rapid method of quantification of tight-junction organization using image analysis","volume":"83","author":"Terryn","year":"2013","journal-title":"Cytometry A"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00484","article-title":"Neutrophils discriminate between lipopolysaccharides of different bacterial sources and selectively release neutrophil extracellular traps","volume":"7","author":"Pieterse","year":"2016","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-06-290171","article-title":"Myeloperoxidase is required for neutrophil extracellular trap formation: implications for innate immunity","volume":"117","author":"Metzler","year":"2011","journal-title":"Blood"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0800377","article-title":"Myeloperoxidase deficiency attenuates lipopolysaccharide-induced acute lung inflammation and subsequent cytokine and chemokine production","volume":"182","author":"Haegens","year":"2009","journal-title":"J Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.53.11.2950","article-title":"Leukocyte-derived myeloperoxidase amplifies high-glucose\u2013induced endothelial dysfunction through interaction with high-glucose\u2013stimulated, vascular non\u2013leukocyte-derived reactive oxygen species","volume":"53","author":"Zhang","year":"2004","journal-title":"Diabetes"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1551256\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T07:04:24Z","timestamp":1740985464000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1551256\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,3]]},"references-count":23,"alternative-id":["10.3389\/fimmu.2025.1551256"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1551256","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,3]]},"article-number":"1551256"}}